Skip to content

Long-term efficacy of tube shunt sugery for glaucoma

Long-term efficacy of tube shunt sugery for glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125126
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. primary glaucoma

Interventions

Aqueous humor drainage valve implantation group:None

Sponsors

The Zhongshan Ophthalmic Center,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age: 0-85 years; 2. Accept tube shunt surgery in Zhongshan Ophthalmic Center from 2016.1.1 to 2024.12.31; 3. Sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Uveitis recurrence or iris neovascularization due to elevated intraocular pressure; 2. combined with other ocular disease : such as diabetic retinopathy, age-related macular degeneration, optic neuropathy, ocular trauma, strabismus, nystagmus, severe dry eye, blepharoptosis; 3. History of severe systematic disease : diabetes, hypertension(SBP= 160mmHg or DBP= 100mmHg), heart disease, kidney disease, rheumatology and immunology disease, digestive system disease, and tumors;

Design outcomes

Primary

MeasureTime frame
Intraocular Pressure;

Secondary

MeasureTime frame
Number of Anti-glaucoma Medications and Changes Thereof;Surgical Complications;Reoperation for Glaucoma;Best Corrected Visual Acuity (BCVA);Visual field MD and PSD values;Corneal Endothelial Cell Count and Changes Thereof;Use of Mitomycin C (MMC);

Countries

China

Contacts

Public ContactZhang Xiulan

The Zhongshan Ophthalmic Center,Sun Yat-sen University

xiulan_z@qq.com+86 20 66610720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026